Background: Adhesive Capsulitis is a painful condition commonly occurring in the middle age group population causing disability in the population and hence we conducted the present study with the aim to describe the pain and disability assessment in patients of adhesive capsulitis treated with and without injectable corticosteroids (hydrodilatation). Methodology: A prospective study was conducted from June 2018 to March 2020 for a period of 2 years, at a tertiary care hospital. The sample size included 40 patients with the diagnosis of adhesive capsulitis divided into 2 groups randomly. SPADI score was calculated and p__ampersandsignlt;0.05 was considered significant. Results: SPADI score was performed on pre-injection day and on 3rd, 6th, 12thand 16th week in the two groups. The mean pre-intervention score in the steroid group was (75.18) which improved on follow up weeks 3rdwk (49), 6thwk (40.45), 12th (39.10), and 16thwk (31). Similarly, the SPADI score for the saline group was (75.05) pre-intervention which also improved on the review weeks as on 3rdwk (65), 6thwk (64.95), 12thwk (56.15), and 16th week (40.40). On comparing the mean score of saline and steroid group, there was more improvement in range of motion and pain in the patients of steroid group. The mean score observed on 16th week post-intervention in steroid group was (31) and that in the saline group was (40.40) Conclusion: Comparison between steroid hydrodilatation and saline hydrodilatation was suggestive of, as steroid hydrodilatation being a better modality of treatment for pain relief and improvement in shoulder mobility when compared on SPADI Score.